Premium
Is N‐terminal pro‐brain natriuretic peptide superior to clinical scores for risk stratification in non‐massive pulmonary embolism?
Author(s) -
VUILLEUMIER N.,
LE GAL G.,
CORNILY J. C.,
HOCHSTRASSER D.,
BOUNAMEAUX H.,
AUJESKY D.,
RIGHINI M.
Publication year - 2010
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2010.03879.x
Subject(s) - medicine , pulmonary embolism , risk stratification , confidence interval , prospective cohort study , clinical trial , brain natriuretic peptide , ambulatory , randomized controlled trial , risk assessment , n terminal pro brain natriuretic peptide , intensive care medicine , biomarker , cardiology , natriuretic peptide , heart failure , computer science , biochemistry , chemistry , computer security